Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
India
(17/week)
United States of America
(16/week)
Uzbekistan
(2/week)
Canada
(2/week)
China, P. R.
(1/week)
View all
(43/week)
News
United States
(1556/week)
Manufacturing
(780/week)
Energy
(584/week)
Technology
(1419/week)
Engineering
(562/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Compugen Ltd.
Mar 26, 2025
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
Feb 18, 2025
Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025
Feb 04, 2025
Compugen to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Jan 08, 2025
Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors
Nov 05, 2024
Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
Oct 29, 2024
Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Oct 07, 2024
Compugen to Present New Clinical Data at SITC 2024
Sep 09, 2024
Compugen to Present at Single Cell Genomics 2024 Conference
Aug 29, 2024
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Aug 06, 2024
Compugen Reports Second Quarter 2024 Results
Jul 29, 2024
Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors
Jul 23, 2024
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024
Jun 17, 2024
Compugen to Present at Upcoming Antibody Industrial Symposium
May 30, 2024
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
May 20, 2024
Compugen Reports First Quarter 2024 Results
May 16, 2024
Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
May 15, 2024
Compugen Appoints David Silberman as Chief Financial Officer
May 06, 2024
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
Apr 25, 2024
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
Apr 10, 2024
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Page 1
››
Latest News
May 4, 2025
Israel army says missile that hit airport area was fired from Yemen
May 4, 2025
British Airways suspends Tel Aviv flights until May 7
May 4, 2025
Two dead as small plane crashes into California neighborhood
May 4, 2025
Missile hits Israel airport area in Huthi-claimed attack
May 4, 2025
Air India suspends flights to Tel Aviv to May 6 after airport attack
May 4, 2025
Lufthansa suspends Tel Aviv flights to May 6 after airport attack
May 4, 2025
Israel security cabinet to meet at 1600 GMT Sunday: official
May 4, 2025
Hamas hails Huthi-claimed strike on Israeli airport
View all News
Agenda
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
21
May
United Kingdom
London, UK
Space Operations Summit, 21 - 22 May 2025, London, UK
Space Operations Summit | 21 - 22 May, 2025 | London, UK Space Operations Summit 2025 is the only conference to look at...
13
May
United States of America
Westin Lake Las Vegas Resort and Spa, Henderson, NV
Air Dominance Summit, May 13 - 14, 2025, Westin Lake Las Vegas Resort and Spa, Henderson, NV
Air Dominance Summit | May 13 - 14, 2025 | Westin Lake Las Vegas Resort and Spa, Henderson, NV SECURING AIR SUPREMACY...
View All Events